TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive Also in This 8-page Issue: In Overhaul of Ethics Rules, NIH Bans Employees From Consulting for and Owning Stock in Biomedical Companies. February 4, 2005